elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36326389-8C51F331-4B21-49DE-84F5-C0B7E914F94A
Q36326389-8C51F331-4B21-49DE-84F5-C0B7E914F94A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36326389-8C51F331-4B21-49DE-84F5-C0B7E914F94A
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials.
P2860
Q36326389-8C51F331-4B21-49DE-84F5-C0B7E914F94A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36326389-8C51F331-4B21-49DE-84F5-C0B7E914F94A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
66d166f65d64e3cf7d5e25ee5455c3b396a38a82
P2860
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: a review of the literature.